Impact of Implementing the Modified A-DIVA Scale on Successful Access to a Venous Line on the First Attempt

NCT ID: NCT06062199

Last Updated: 2025-04-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-27

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Peripheral venous access (PVA), although commonly used, can be a difficult procedure for patients with precarious venous capital. The difficulty of insertion can lead to multiple attempts, with the consequences of pain, anxiety, delayed management and worsening of the potentially already precarious venous capital. One study assessed the risk of failure according to a score based on venous status criteria. This study first established a link between venous status criteria and the risk of failure. The criteria defined as determinants were used to establish a venous status score. The data were then repeated by analyzing the success rate as a function of the scale score. A clear link between score and risk of failure was established. It seems worthwhile to evaluate the impact of implementing this scale prior to the placement of a peripheral venous line.

The hypothesis is that obtaining a score predictive of failure would modify the therapeutic attitude of the registered nurse. They would opt for techniques that would increase their chances of success. This in turn would lead to a reduction in unsuccessful attempts, which generate pain and anxiety for the patient. Preserving venous capital by increasing first-attempt success is both a health issue for the patient and a guarantee of quality of care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control arm

Nurses will place a peripheral venous line on these patients without having been trained in the venous status score predictive of failure.

Group Type NO_INTERVENTION

No interventions assigned to this group

Experimental arm

Nurses will place a peripheral venous line on these patients after being trained in the venous status score predictive of failure.

Group Type EXPERIMENTAL

Training in the A-DIVA scale and its failure prediction score

Intervention Type PROCEDURE

Nurses are trained in the A-DIVA scale and its predictive failure score. This score enables them to adapt their approach to peripheral venous line insertion.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Training in the A-DIVA scale and its failure prediction score

Nurses are trained in the A-DIVA scale and its predictive failure score. This score enables them to adapt their approach to peripheral venous line insertion.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female patient of legal age included in a care program requiring a VVP;
* Fluency in French
* Patient affiliated to a social security scheme;
* Written, signed and dated informed consent.

Exclusion Criteria

* As the A-DIVA scale specifies a search for venous access to the upper limb, any patient without an upper limb or with a condition that contraindicates VVP placement in the upper limbs will be excluded;
* Patients treated as emergencies;
* Patients with a language barrier or known significant cognitive or psychiatric disorders;
* Patients under guardianship, curatorship, deprivation of liberty or legal protection;
* Pregnant or breast-feeding women.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Jean Perrin

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lucie MADELAINE

Role: STUDY_DIRECTOR

Centre Jean Perrin

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Gabriel Montpied

Clermont-Ferrand, , France

Site Status NOT_YET_RECRUITING

Centre Jean PERRIN

Clermont-Ferrand, , France

Site Status RECRUITING

Hôpital de la Croix Rousse

Lyon, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Judith PASSILDAS JAHANMOHAN, PhD

Role: CONTACT

+33473278005

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Virginie HAUTEMAYOU

Role: primary

Judith PASSILDAS JAHANMOHAN, PhD

Role: primary

Charline TAUREAU

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A01480-45

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Accuvein in Adult Patients
NCT01020461 TERMINATED PHASE4